Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Consolidated Net Income (2016 - 2024)

Historic Consolidated Net Income for Select Medical Holdings (SEM) over the last 16 years, with Q4 2024 value amounting to $14.2 million.

  • Select Medical Holdings' Consolidated Net Income fell 5494.98% to $14.2 million in Q4 2024 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year decrease of 9382.87%. This contributed to the annual value of $223.4 million for FY2024, which is 792.06% down from last year.
  • According to the latest figures from Q4 2024, Select Medical Holdings' Consolidated Net Income is $14.2 million, which was down 5494.98% from $62.2 million recorded in Q3 2024.
  • Select Medical Holdings' 5-year Consolidated Net Income high stood at $196.2 million for Q2 2021, and its period low was -$141.8 million during Q4 2022.
  • Over the past 5 years, Select Medical Holdings' median Consolidated Net Income value was $65.8 million (recorded in 2022), while the average stood at $63.3 million.
  • In the last 5 years, Select Medical Holdings' Consolidated Net Income surged by 19073.88% in 2021 and then tumbled by 31379.73% in 2022.
  • Quarter analysis of 5 years shows Select Medical Holdings' Consolidated Net Income stood at $102.2 million in 2020, then plummeted by 35.13% to $66.3 million in 2021, then tumbled by 313.8% to -$141.8 million in 2022, then surged by 122.25% to $31.5 million in 2023, then crashed by 54.95% to $14.2 million in 2024.
  • Its Consolidated Net Income stands at $14.2 million for Q4 2024, versus $62.2 million for Q3 2024 and $71.2 million for Q2 2024.